- Apple Watch fans should recover the blood oxygen function on certain watches, after a lawsuit of the Masimo Health Technology Company
- Functionality now implies a slight bypass solution, to which the extent can only be displayed on an iPhone
- Masimo continues the American customs service for having allowed the bypass solution to move forward
In the United States, Apple Watch users are finally about to recover health functionality, because the Watchos 26 public beta was launched with access to blood oxygen functionality – in a way.
The functionality was removed for American fans after the health technology company Masimo continued Apple, saying that it had voluntarily violated the intellectual property of Masimo via its patented characteristic of blood oxygen. Consequently, the functionality was temporarily deactivated on the Apple Watch Series 9, Apple Watch Series 10 and Apple Watch Ultra 2.
However, a bypass solution noted that the Apple Watch was able to add the functionality via its new Watchos 26 software, and it has already arrived on certain watches participating in the Apple Public Beta program.
The bypass solution is that, although the Apple Watch can record blood oxygen, it cannot present this information from the Health application on an iPhone.
Masimo does not like it and has filed another trial – this time, targeting us customs, rather than Apple himself. Masimo continues the US government for (according to the trial via this BGR report), “[ting] Apple Inc. reactivates a blood-oxygen monitoring function on Apple watches that harm patents for technology “.
Will I obtain a monitoring of blood oxygen on my Apple watch?
We don’t know. For the moment, if you are registered in the beta public program, you should already have the functionality.
Whether it will survive until the broader deployment in September or the US government feels under pressure by this trial to act and prohibit the bypass solution.
